Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
YERXA BENJAMIN R Insider Profile
4 Followers
YERXA BENJAMIN R, Director at Clearside Biomedical, holds 332.80K shares in Opus Genetics (Ticker: IRD), holds 17.96K shares in Clearside Biomedical (Ticker: CLSD).
YERXA BENJAMIN R has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that YERXA BENJAMIN R holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by YERXA BENJAMIN R
YERXA BENJAMIN R's Trading History
Clearside Biomedical
May 15, 2024
Director
Informative Buy
10.24K
$18.85K
Opus Genetics
Nov 12, 2024
President, Director
Uninformative Buy
―
$326.14K
List of latest transactions for each holding click on a transaction to see YERXA BENJAMIN R's performance on stock
You May Also Like
YERXA BENJAMIN R insider profile FAQ
What is the percentage of profitable transactions made by YERXA BENJAMIN R?
The percentage of profitable transactions made by YERXA BENJAMIN R is ―.
What is the average return per transaction made by YERXA BENJAMIN R?
The average return per transaction made by YERXA BENJAMIN R is ―.
What stocks does YERXA BENJAMIN R hold?
YERXA BENJAMIN R holds: CLSD, IRD stocks.
What was YERXA BENJAMIN R’s latest transaction?
YERXA BENJAMIN R latest transaction was an Uninformative Buy of ―.
What was YERXA BENJAMIN R's most profitable transaction?
YERXA BENJAMIN R’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is YERXA BENJAMIN R's role in Clearside Biomedical?
YERXA BENJAMIN R's role in Clearside Biomedical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.